These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8472352)

  • 1. Urinary neopterin as a predictive marker of coronary artery abnormalities in Kawasaki syndrome.
    Iizuka T; Minatogawa Y; Suzuki H; Itoh M; Nakamine S; Hatanaka Y; Uemura S; Koike M
    Clin Chem; 1993 Apr; 39(4):600-4. PubMed ID: 8472352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and aneurysm formation in Kawasaki disease.
    Iizuka T; Oishi K; Sasaki M; Hatanaka Y; Minatogawa Y; Uemura S; Koike M
    Acta Paediatr; 1997 May; 86(5):470-3. PubMed ID: 9183484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
    Ohno T; Igarashi H; Inoue K; Akazawa K; Joho K; Hara T
    Eur J Pediatr; 2000 Jun; 159(6):424-9. PubMed ID: 10867847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease].
    Song RX; Li XH; Zhang T; Cui XD; Fu J
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):259-63. PubMed ID: 27055423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease.
    Mori Y; Katayama H; Kishi K; Ozaki N; Shimizu T; Tamai H
    J Cardiol; 2016 Jul; 68(1):71-5. PubMed ID: 26381328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid regression of coronary dilatation in Kawasaki disease with intravenous gamma-globulin.
    Saalouke MG; Venglarcik JS; Baker DR; Saalouke ZI; Bashour TT
    Am Heart J; 1991 Mar; 121(3 Pt 1):905-9. PubMed ID: 1705749
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome.
    Drenth JP; Powell RJ; Brown NS; Van der Meer JW
    Eur J Clin Invest; 1995 Sep; 25(9):683-6. PubMed ID: 7498243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease.
    Samada K; Igarashi H; Shiraishi H; Hatake K; Momoi MY
    Eur J Pediatr; 2002 Oct; 161(10):538-41. PubMed ID: 12297900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary neopterin as a new biochemical marker for the monitoring of disease activity and prognosis in membranous nephropathy associated with hepatitis B surface antigenemia.
    Lin CY
    Nephron; 1989; 53(2):115-20. PubMed ID: 2510033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.
    Fuchs D; Spira TJ; Hausen A; Reibnegger G; Werner ER; Felmayer GW; Wachter H
    Clin Chem; 1989 Aug; 35(8):1746-9. PubMed ID: 2635886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease.
    Anderson MS; Burns J; Treadwell TA; Pietra BA; Glodé MP
    Pediatr Infect Dis J; 2001 Jul; 20(7):698-702. PubMed ID: 11465843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases.
    Biezeveld MH; van Mierlo G; Lutter R; Kuipers IM; Dekker T; Hack CE; Newburger JW; Kuijpers TW
    Clin Exp Immunol; 2005 Jul; 141(1):183-8. PubMed ID: 15958085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation in vivax malaria: fever is associated with increased levels of neopterin and interferon-gamma.
    Brown AE; Teja-Isavadharm P; Webster HK
    Parasite Immunol; 1991 Nov; 13(6):673-9. PubMed ID: 1811217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki syndrome.
    Rowley AH; Gonzalez-Crussi F; Shulman ST
    Rev Infect Dis; 1988; 10(1):1-15. PubMed ID: 3281216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for persistence of coronary artery abnormalities in Turkish children with Kawasaki disease.
    Yılmazer MM; Öner T; Gökalp S; Doksöz Ö; Güven B; Vupa-Çilengiroğlu Ö; Meşe T; Tavlı V
    Turk J Pediatr; 2015; 57(3):248-53. PubMed ID: 26701943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Inducible Nitric Oxide Levels and Decreased Hydrogen Sulfide Levels Can Predict the Risk of Coronary Artery Ectasia in Kawasaki Disease.
    Song R; Liu G; Li X; Xu W; Liu J; Jin H
    Pediatr Cardiol; 2016 Feb; 37(2):322-9. PubMed ID: 26499359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of value of procalcitonin for prediction of coronary aneurysms in Kawasaki disease.
    Catalano-Pons C; André MC; Chalumeau M; Guérin S; Gendrel D
    Pediatr Infect Dis J; 2007 Feb; 26(2):179-80. PubMed ID: 17259884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.